Evidence map›Paper›PMID 32040376›Full record

Trial reportHuman vaccines & immunotherapeutics2020

Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction.

Yongji Wang, Yangyang Qi, Wenguo Xu, Yuansheng Hu, Ling Wang, Yongpei Yu, Zhiwei Jiang, Jielai Xia, Gang Zeng, Yalong Wang

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. [Expert recommendations on hepatitis A vaccination for adults].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yongji WangDepartment of Health Statistics, School of Preventive Medicine, Air Force Military Medical University , Xi'an, Shaanxi, China.
Yangyang QiDepartment of Statistics, Beijing Key Tech Statistical Consulting Co., Ltd , Beijing, China.ORCID 0000-0001-9139-9675
Wenguo XuDepartment of Immunization Planning, Center for Disease Control and Prevention of Changzhou City , Changzhou, Jiangsu, China.
Yuansheng HuDepartment of Clinical Research, Sinovac Biotech , Beijing, China.
Ling WangDepartment of Health Statistics, School of Preventive Medicine, Air Force Military Medical University , Xi'an, Shaanxi, China.
Yongpei YuDepartment of Statistics, Peking University Clinical Research Institute, Peking University Health Science Center , Beijing, China.
Zhiwei JiangDepartment of Statistics, Beijing Key Tech Statistical Consulting Co., Ltd , Beijing, China.
Jielai XiaDepartment of Health Statistics, School of Preventive Medicine, Air Force Military Medical University , Xi'an, Shaanxi, China.ORCID 0000-0003-1137-3198
Gang ZengDepartment of Clinical Research, Sinovac Biotech , Beijing, China.
Yalong WangDepartment of Immunization Planning, Center for Disease Control and Prevention of Changzhou City , Changzhou, Jiangsu, China.
Nanjing Municipal Center for Disease Control And Prevention · CNSinovac Biotech · CNPeking University · CNAir Force Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis AHepatitis A VaccinesChildChinaFollow-Up StudiesHepatitis A AntibodiesHumansImmunization, SecondaryProspective StudiesVaccines, InactivatedHepatitis A AntibodiesHepatitis A VaccinesVaccines, InactivatedHepatitis Aimmunogenicitylong termpersistenceseroprotectionvaccine

Identifiers

PMID32040376
PMCPMC7644183
OpenAlexW3005140766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.